Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,600 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Follow-Up Questions
Artivion Inc 'in CEO'su kimdir?
Mr. James Mackin 2014 'den beri şirketle birlikte olan Artivion Inc 'in Chairman of the Board 'ıdır.
AORT hissesinin fiyat performansı nasıl?
AORT 'in mevcut fiyatı $40.61 'dir, son işlem günde 1.8% decreased etti.
Artivion Inc için ana iş temaları veya sektörler nelerdir?
Artivion Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Artivion Inc 'in piyasa değerlemesi nedir?
Artivion Inc 'in mevcut piyasa değerlemesi $1.9B 'dir
Artivion Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 9 analist Artivion Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 7 al, 2 tut, 0 sat ve 4 güçlü sat içermektedir